Back to search
FDAFDA · Food and drugs·Recall number D-1062-2016

Cyproheptadine Hydrochloride Syrup, Oral Solution USP, 2 mg/5 mL, packaged in an amber glass 473 mL (one pint) bottle with child-resistant screw closure, Rx only, Distributed by: Rising Pharmaceuticals, Inc., Allendale, NJ 07401, Manufactured by: Lyne Laboratories, Inc., Brockton, MA 02301, NDC 64980-0504-48

Published July 13, 2016 · Recall initiated: June 7, 2016

Summary

FDA records drug Class III recall D-1062-2016, published July 13, 2016 and initiated June 7, 2016. Recalling firm: Lyne Laboratories, Inc.; Status: Terminated; Reported quantity: 12,215 Bottles shipped to Rising Pharmaceuticals; Lot: Lot #: CR1603, Exp 12/17. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotency: product assayed and found OOS for cyproheptadine

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Lyne Laboratories, Inc.
Distributor
NJ
Lot
Lot #: CR1603, Exp 12/17
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Cyproheptadine Hydrochloride Syrup, Oral Solution USP, 2 mg/5 mL, packaged in an amber glass 473 mL (one pint) bottle with child-resistant screw closure, Rx only, Distributed by: Rising Pharmaceuticals, Inc., Allendale, NJ 07401, Manufactured by: Lyne Laboratories, Inc., Brockton, MA 02301, NDC 64980-0504-48 recalled?

Yes. FDA published recall D-1062-2016 on July 13, 2016. Reported hazard: Subpotency: product assayed and found OOS for cyproheptadine

What should I do if I have this product?

Voluntary: Firm initiated · Letter